The impact of admission neutrophil-to-platelet ratio on in-hospital and long-term mortality in patients with infective endocarditis

Xue-biao Wei 1 , Yuan-hui Liu 1 , Peng-cheng He 1 , Dan-qing Yu 1 , Ning Tan 1 , Ying-ling Zhou 1 ,  and Ji-yan Chen 1
  • 1 Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P.R. China
Xue-biao Wei, Yuan-hui Liu, Peng-cheng He, Dan-qing Yu, Ning Tan, Ying-ling Zhou and Ji-yan Chen

Abstract

Background:

Infective endocarditis (IE) is associated with increased neutrophil and reduced platelet counts. We assessed the relationship between the neutrophil-to-platelet ratio (NPR) on admission and adverse outcomes in patients with IE.

Methods:

Patients diagnosed with IE between January 2009 and July 2015 (n=1293) were enrolled, and 1046 were finally entered into the study. Study subjects were categorized into four groups according to NPR quartiles: Q1<18.9 (n=260); Q2: 18.9–27.7 (n=258); Q3: 27.7–43.3 (n=266); and Q4>43.3 (n=262). Cox proportional hazards regression was performed to identify risk factors for long-term mortality; the optimal cut-off was evaluated by receiver operating characteristic curves.

Results:

Risk of in-hospital death increased progressively with NPR group number (1.9 vs. 5.0 vs. 9.8 vs. 14.1%, p<0.001). The follow-up period was a median of 28.8 months, during which 144 subjects (14.3%) died. Long-term mortality increased from the lowest to the highest NPR quartiles (7.6, 11.8, 17.4, and 26.2%, respectively, p<0.001). Multivariate Cox proportional hazard analysis revealed that lgNPR (HR=2.22) was an independent predictor of long-term mortality. Kaplan-Meier survival curves showed that subjects in Q4 had an increased long-term mortality compared with the other groups.

Conclusions:

Increased NPR was associated with in-hospital and long-term mortality in patients with IE. As a simple and inexpensive index, NPR may be a useful and rapid screening tool to identify IE patients at high risk of mortality.

  • 1.

    Ternhag A, Cederstrom A, Torner A, Westling K. A nationwide cohort study of mortality risk and long-term prognosis in infective endocarditis in Sweden. PLoS One 2013;8:e67519.

    • Crossref
    • PubMed
    • Export Citation
  • 2.

    Thuny F, Giorgi R, Habachi R, Ansaldi S, Le Dolley Y, Casalta JP, et al. Excess mortality and morbidity in patients surviving infective endocarditis. Am Heart J 2012;164:94–101.

    • Crossref
    • PubMed
    • Export Citation
  • 3.

    Fernandez-Hidalgo N, Almirante B, Tornos P, Gonzalez-Alujas MT, Planes AM, Galinanes M, et al. Immediate and long-term outcome of left-sided infective endocarditis. A 12-year prospective study from a contemporary cohort in a referral hospital. Clin Microbiol Infect 2012;18:E522–30.

    • Crossref
    • Export Citation
  • 4.

    Mokhles MM, Ciampichetti I, Head SJ, Takkenberg JJ, Bogers AJ. Survival of surgically treated infective endocarditis: a comparison with the general Dutch population. Ann Thorac Surg 2011;91:1407–12.

    • Crossref
    • PubMed
    • Export Citation
  • 5.

    Heiro M, Helenius H, Hurme S, Savunen T, Metsarinne K, Engblom E, et al. Long-term outcome of infective endocarditis: a study on patients surviving over one year after the initial episode treated in a Finnish teaching hospital during 25 years. BMC Infect Dis 2008;8:49.

    • Crossref
    • Export Citation
  • 6.

    Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni E, et al. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. J Am Med Assoc Intern Med 2013;173:1495–504.

  • 7.

    Delahaye F, Alla F, Beguinot I, Bruneval P, Doco-Lecompte T, Lacassin F, et al. In-hospital mortality of infective endocarditis: prognostic factors and evolution over an 8-year period. Scand J Infect Dis 2007;39:849–57.

    • Crossref
    • PubMed
    • Export Citation
  • 8.

    Klein M, Wang A. Infective Endocarditis. J Intensive Care Med 2016;31:151–63.

    • Crossref
    • PubMed
    • Export Citation
  • 9.

    Heiro M, Helenius H, Sundell J, Koskinen P, Engblom E, Nikoskelainen J, et al. Utility of serum C-reactive protein in assessing the outcome of infective endocarditis. Eur Heart J 2005;26:1873–81.

    • Crossref
    • PubMed
    • Export Citation
  • 10.

    Turak O, Ozcan F, Isleyen A, Basar FN, Gul M, Yilmaz S, et al. Usefulness of neutrophil-to-lymphocyte ratio to predict in-hospital outcomes in infective endocarditis. Can J Cardiol 2013;29:1672–8.

    • Crossref
    • PubMed
    • Export Citation
  • 11.

    Drews RE, Weinberger SE. Thrombocytopenic disorders in critically ill patients. Am J Respir Crit Care Med 2000;162(2 Pt 1):347–51.

    • Crossref
    • PubMed
    • Export Citation
  • 12.

    Cho SY, Jeon YL, Kim W, Kim WS, Lee HJ, Lee WI, et al. Mean platelet volume and mean platelet volume/platelet count ratio in infective endocarditis. Platelets 2014;25:559–61.

    • Crossref
    • PubMed
    • Export Citation
  • 13.

    Ferrera C, Vilacosta I, Fernandez C, Lopez J, Sarria C, Olmos C, et al. Usefulness of thrombocytopenia at admission as a prognostic marker in native valve left-sided infective endocarditis. Am J Cardiol 2015;115:950–5.

    • Crossref
    • PubMed
    • Export Citation
  • 14.

    Sy RW, Chawantanpipat C, Richmond DR, Kritharides L. Development and validation of a time-dependent risk model for predicting mortality in infective endocarditis. Eur Heart J 2011;32:2016–26.

    • Crossref
    • PubMed
    • Export Citation
  • 15.

    Li JS, Sexton DJ, Mick N, Nettles R, Fowler VJ, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633–8.

    • Crossref
    • Export Citation
  • 16.

    Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006;17:2937–44.

    • Crossref
    • PubMed
    • Export Citation
  • 17.

    Angeletti S, Battistoni F, Fioravanti M, Bernardini S, Dicuonzo G. Procalcitonin and mid-regional pro-adrenomedullin test combination in sepsis diagnosis. Clin Chem Lab Med 2013;51:1059–67.

    • PubMed
    • Export Citation
  • 18.

    Angeletti S, Dicuonzo G, Fioravanti M, De Cesaris M, Fogolari M, Lo PA, et al. Procalcitonin, MR-proadrenomedullin, and cytokines measurement in sepsis diagnosis: advantages from test combination. Dis Markers 2015;2015:951532.

    • PubMed
    • Export Citation
  • 19.

    Angeletti S, Spoto S, Fogolari M, Cortigiani M, Fioravanti M, De Florio L, et al. Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-adrenomedullin (MR-proADM) in bacterial infections. Apmis 2015;123:740–8.

    • Crossref
    • PubMed
    • Export Citation
  • 20.

    Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del ZF, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36:3075–128.

  • 21.

    Tok D, Canpolat U, Tok D, Turak O, Isleyen A, Oksuz F, et al. Association of mean platelet volume level with in-hospital major adverse events in infective endocarditis. Wien Klin Wochenschr 2015;127:197–202.

    • Crossref
    • PubMed
    • Export Citation
  • 22.

    Turak O, Canpolat U, Ozcan F, Yayla C, Mendi MA, Oksuz F, et al. D-dimer level predicts in-hospital mortality in patients with infective endocarditis: a prospective single-centre study. Thromb Res 2014;134:587–92.

    • Crossref
    • PubMed
    • Export Citation
  • 23.

    Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 2013;13:159–75.

    • Crossref
    • PubMed
    • Export Citation
  • 24.

    Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. Neutrophil function: from mechanisms to disease. Annu Rev Immunol 2012;30:459–89.

    • Crossref
    • PubMed
    • Export Citation
  • 25.

    O’Hartaigh B, Bosch JA, Thomas GN, Lord JM, Pilz S, Loerbroks A, et al. Which leukocyte subsets predict cardiovascular mortality? From the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Atherosclerosis 2012;224:161–9.

    • Crossref
    • PubMed
    • Export Citation
  • 26.

    Laki K. Our ancient heritage in blood clotting and some of its consequences. Ann N Y Acad Sci 1972;202:297–307.

    • Crossref
    • PubMed
    • Export Citation
  • 27.

    Thomas MR, Storey RF. The role of platelets in inflammation. Thromb Haemost 2015;114:449–58.

    • Crossref
    • PubMed
    • Export Citation
  • 28.

    Koenen RR. The prowess of platelets in immunity and inflammation. Thromb Haemost 2016;116:605–12.

    • Crossref
    • PubMed
    • Export Citation
  • 29.

    Dore M, Korthuis RJ, Granger DN, Entman ML, Smith CW. P-selectin mediates spontaneous leukocyte rolling in vivo. Blood 1993;82:1308–16.

    • Crossref
    • PubMed
    • Export Citation
  • 30.

    Moore KL, Patel KD, Bruehl RE, Li F, Johnson DA, Lichenstein HS, et al. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol 1995;128:661–71.

    • Crossref
    • PubMed
    • Export Citation
  • 31.

    Ma YQ, Plow EF, Geng JG. P-selectin binding to P-selectin glycoprotein ligand-1 induces an intermediate state of alphaMbeta2 activation and acts cooperatively with extracellular stimuli to support maximal adhesion of human neutrophils. Blood 2004;104:2549–56.

    • Crossref
    • PubMed
    • Export Citation
  • 32.

    Bayer AS, Sullam PM, Ramos M, Li C, Cheung AL, Yeaman MR. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains. Infect Immun 1995;63:3634–41.

    • Crossref
    • Export Citation
  • 33.

    Niemann S, Spehr N, Van Aken H, Morgenstern E, Peters G, Herrmann M, et al. Soluble fibrin is the main mediator of Staphylococcus aureus adhesion to platelets. Circulation 2004;110:193–200.

    • Crossref
    • PubMed
    • Export Citation
  • 34.

    Cahill TJ, Prendergast BD. Infective endocarditis. Lancet 2016;387:882–93.

    • Crossref
    • PubMed
    • Export Citation
  • 35.

    Vincent JL, Yagushi A, Pradier O. Platelet function in sepsis. Crit Care Med 2002;30(5 Suppl):S313–7.

    • Crossref
    • PubMed
    • Export Citation
  • 36.

    Yaguchi A, Lobo FL, Vincent JL, Pradier O. Platelet function in sepsis. J Thromb Haemost 2004;2:2096–102.

    • Crossref
    • PubMed
    • Export Citation
  • 37.

    Gawaz M, Dickfeld T, Bogner C, Fateh-Moghadam S, Neumann FJ. Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med 1997;23:379–85.

    • Crossref
    • PubMed
    • Export Citation
  • 38.

    Cox D, Kerrigan SW, Watson SP. Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost 2011;9:1097–107.

    • Crossref
    • PubMed
    • Export Citation
  • 39.

    Ghosh TK, Khan N, Malik A. Platelet auto-antibodies in septicaemic patients. Indian J Pathol Microbiol 1999;42:31–5.

    • PubMed
    • Export Citation
  • 40.

    Francois B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med 1997;103:114–20.

    • Crossref
    • PubMed
    • Export Citation
  • 41.

    Sy RW, Chawantanpipat C, Richmond DR, Kritharides L. Thrombocytopenia and mortality in infective endocarditis. J Am Coll Cardiol 2008;51:1824–5.

    • Crossref
    • PubMed
    • Export Citation
Purchase article
Get instant unlimited access to the article.
$42.00
Log in
Already have access? Please log in.


or
Log in with your institution

Journal + Issues

Clinical Chemistry and Laboratory Medicine ( CCLM) publishes articles on novel teaching and training methods applicable to laboratory medicine. CCLM welcomes contributions on the progress in fundamental and applied research and cutting-edge clinical laboratory medicine. It is one of the leading journals in the field, with an impact factor of over three. CCLM is the official journal of nine national clinical societies and associated with EFLM.

Search